A recent study has shown that the anti-TcdB antibody can significantly delay recurrence of CDI. The effect of the anti-TcdB antibody was more pronounced in patients aged 65 years and older. The study also found that the protective effect of the toxin B antibody was independent of age. A new molecule, TcdB, binds to the […]